DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65:401–21.

Article  PubMed  Google Scholar 

Lee NY, Ferris RL, Psyrri A, Haddad RI, Tahara M, Bourhis J, et al. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol. 2021;22:450–62.

Article  CAS  PubMed  Google Scholar 

Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. 2015;31:28–35.

Article  CAS  PubMed  Google Scholar 

Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell. 2015;16:225–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du L, Cheng Q, Zheng H, Liu J, Liu L, Chen Q. Targeting stemness of cancer stem cells to fight colorectal cancers. Semin Cancer Biol. 2022;82:150–61.

Article  PubMed  Google Scholar 

Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124–34.

Article  CAS  PubMed  Google Scholar 

Kaushik V, Kulkarni Y, Felix K, Azad N, Iyer AKV, Yakisich JS. Alternative models of cancer stem cells: the stemness phenotype model, 10 years later. World J Stem Cells. 2021;13:934–43.

Article  PubMed  PubMed Central  Google Scholar 

Pekkurnaz G, Wang X. Mitochondrial heterogeneity and homeostasis through the lens of a neuron. Nat Metab. 2022;4:802–12.

Article  PubMed  Google Scholar 

Chen H, Chan DC. Mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells. Cell Metab. 2017;26:39–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fonseca TB, Sánchez-Guerrero Á, Milosevic I, Raimundo N. Mitochondrial fission requires DRP1 but not dynamins. Nature. 2019;570:E34–E42.

Article  CAS  PubMed  Google Scholar 

Chung KP, Hsu CL, Fan LC, Huang Z, Bhatia D, Chen YJ, et al. Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis. Nat Commun. 2019;10:3390.

Article  PubMed  PubMed Central  Google Scholar 

Baker N, Wade S, Triolo M, Girgis J, Chwastek D, Larrigan S, et al. The mitochondrial protein OPA1 regulates the quiescent state of adult muscle stem cells. Cell Stem Cell. 2022;29:1315–1332.e9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khacho M, Clark A, Svoboda DS, Azzi J, MacLaurin JG, Meghaizel C, et al. Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program. Cell Stem Cell. 2016;19:232–47.

Article  CAS  PubMed  Google Scholar 

Naik PP, Birbrair A, Bhutia SK. Mitophagy-driven metabolic switch reprograms stem cell fate. Cell Mol Life Sci. 2019;76:27–43.

Article  CAS  PubMed  Google Scholar 

Xie Q, Wu Q, Horbinski CM, Flavahan WA, Yang K, Zhou W, et al. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat Neurosci. 2015;18:501–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vazquez-Martin A, Cufi S, Corominas-Faja B, Oliveras-Ferraros C, Vellon L, Menendez JA. Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemness. Aging. 2012;4:393–401.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prieto J, León M, Ponsoda X, García-García F, Bort R, Serna E, et al. Dysfunctional mitochondrial fission impairs cell reprogramming. Cell Cycle. 2016;15:3240–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schimmer AD. Mitochondrial shapeshifting impacts AML stemness and differentiation. Cell Stem Cell. 2018;23:3–4.

Article  CAS  PubMed  Google Scholar 

Bonnay F, Veloso A, Steinmann V, Köcher T, Abdusselamoglu MD, Bajaj S, et al. Oxidative metabolism drives immortalization of neural stem cells during tumorigenesis. Cell. 2020;182:1490–507.

Article  CAS  PubMed  Google Scholar 

Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012;12:599–612.

Article  CAS  PubMed  Google Scholar 

Liu PS, Wang H, Li X, Chao T, Teav T, Christen S, et al. α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 2017;18:985–94.

Article  CAS  PubMed  Google Scholar 

Zhang Z, He C, Zhang L, Zhu T, Lv D, Li G, et al. Alpha-ketoglutarate affects murine embryo development through metabolic and epigenetic modulations. Reproduction. 2019;158:123–33.

Article  PubMed  Google Scholar 

Lee S, Kim HS, Kim MJ, Min KY, Choi WS, You JS. Glutamine metabolite α-ketoglutarate acts as an epigenetic co-factor to interfere with osteoclast differentiation. Bone. 2021;145:115836.

Article  CAS  PubMed  Google Scholar 

Kang HS, Lee JH, Oh KJ, Lee EW, Han BS, Park KY, et al. IDH1-dependent α-KG regulates brown fat differentiation and function by modulating histone methylation. Metabolism. 2020;105:154–73.

Article  Google Scholar 

Han Y, Villarreal-Ponce A, Gutierrez G Jr, Nguyen Q, Sun P, et al. Coordinate control of basal epithelial cell fate and stem cell maintenance by core EMT transcription factor Zeb1. Cell Rep. 2022;38:110240.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie C, Wang FY, Sang Y, Chen B, Huang JH, He FJ, et al. Mitochondrial micropeptide STMP1 enhances mitochondrial fission to promote tumor metastasis. Cancer Res. 2022;82:2431–43.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Li TE, Chen M, Xu D, Zhu Y, Hu BY, et al. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming. Br J Cancer. 2020;122:209–20.

Article  CAS  PubMed  Google Scholar 

Wang Z, Jiang H, Cai LY, Ji N, Zeng X, Zhou Y, et al. Repurposing disulfiram to induce OSCC cell death by cristae dysfunction promoted autophagy. Oral Dis. 2021;27:1148–60.

Article  PubMed  Google Scholar 

Liu C, Qiang J, Deng Q, Xia J, Deng L, Zhou L, et al. ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Cancer Res. 2021;81:5919–34.

Article  CAS  PubMed  Google Scholar 

Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Xiong X, Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020;5:135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Z, Wang HW, Wang S, Fan L, Feng S, Cai X, et al. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells. J Clin Invest. 2019;129:2043–55.

Article  PubMed  PubMed Central  Google Scholar 

Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, et al. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110.

Article  CAS  PubMed  Google Scholar 

Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368:85–89.

Article  PubMed  PubMed Central  Google Scholar 

Buck MD, O’Sullivan D, Klein Geltink RI, Curtis JD, Chang CH, Sanin DE, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166:63–76.

Article  CAS  PubMed  PubMed Central  Google S

留言 (0)

沒有登入
gif